Finance entity
markets is the sole category represented across all 1 tracked stories. Twist Bioscience is most often covered alongside ARK Invest, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 7 original sources each against 2.6 for the same window.
Last mentioned: Mar 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Twist Bioscience is most often covered alongside ARK Invest, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 7 original sources each against 2.6 for the same window. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. We currently track 1 Finance story that mention Twist Bioscience, all published on March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 84 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Twist Bioscience. Shared-story counts are live from our verified record — not editorial picks.
ARK Invest has executed a strategic shift in its portfolio, divesting from synthetic biology firm Twist Bioscience to increase exposure to Circle Internet. This move signals a rotation from high-growth biotech toward the digital asset infrastructure and stablecoin ecosystem.
Source: Investing South Africa · Investing Philippines
Twist Bioscience is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
